xxAACP Newsletter, Volume 15, Number 3, Summer 2001
The American Psychiatric
Association
in collaboration with the
American Academy of Addiction
Psychiatry
Invites Psychiatrists and Other
Physicians to Attend
"Buprenorphine in
Office-Based
Treatment of Opiate
Dependence"
A Training Course of the APA
Institute
on Psychiatric Services
October 13, 2001
Renaissance Orlando Resort,
Orlando, FL
A new law, passed in late 2000, permits
physicians to directly provide care to opioid dependent patients. Physicians who
complete an eight-hour training course will soon be able to address the
detoxification and withdrawal needs of opioid dependent patients in their own
offices. You will be able to provide compassionate treatment for detoxification
or maintenance to up to 30 patients, but you can only use a schedule III, IV, or
V drug specifically approved by the FDA for the treatment of opioid dependence.
Physician Training for Use of Buprenorphine
Two drugs - buprenorphine and buprenorphine/naloxone
(also known as buprenorphine combo) - are currently under the FDA’s
consideration; the approval process is not yet complete, but approval is
expected within a few months. Buprenorphine is the only drug that will meet the
requirements of the new law in the near future. It promises to be an excellent
tool for psychiatrists, physicians of other specialties, and addiction
specialists.
Get a Waiver for Your Patient’s Sake
Those physicians who seek a waiver from the
Controlled Substances Act prohibition against using scheduled drugs for the
treatment of opioid dependence must hold an addiction certification from
specified professional medical organizations, be associated with the clinical
research trials of buprenorphine, or must complete at least eight hours of
approved training in the treatment and management of opioid dependent patients.
NOTE: The course addresses all the required
areas for physician training identified in the new law. This training meets the
requirements for the Controlled Substance Act waiver.
REGISTRATION INFORMATION
Course:
Office-Based Buprenorphine Treatment
Date:
Saturday, October 13, 2001
Time:
8 a.m. - 5 p.m.
Advance Registration:
Deadline: September 10,
2001
www.psych.org
Click on the IPS icon.
Request preliminary program on-line (www.psych.org)
or call 202-682-6000
On-site Registration:
October 10 - 12, 2001: 7:30 a.m. - 5:30 p.m.
October 13: 7:30 - 8 a.m.
Convention Center Ballrooms I-VIII, First
Floor
Course Fee:
$190 , plus the registration fee for the IPS
The APA designates this educational session for
up to 8.0 hours in category 1 credit t.
Back to Summer 2001 Table Of Contents